Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safe Administration of Flu Vaccine to Egg Allergic Children (SAFE)

This study has been completed.
Sponsor:
Collaborator:
American College of Allergy, Asthma and Immunology
Information provided by (Responsible Party):
Matthew Greenhawt, University of Michigan
ClinicalTrials.gov Identifier:
NCT01264601
First received: December 21, 2010
Last updated: June 6, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)